Literature DB >> 34974960

The dual role of neutrophils in cancer.

Merav E Shaul1, Zvi G Fridlender2.   

Abstract

For the past decade, the role and importance of neutrophils in cancer is being increasingly appreciated. Research has focused on the ability of cancer-related neutrophils to either support tumor growth or interfere with it, showing diverse mechanisms through which the effects of neutrophils take place. In contrast to the historic view of neutrophils as terminally differentiated cells, mounting evidence has demonstrated that neutrophils are a plastic and diverse population of cells. These dynamic and plastic abilities allow them to perform varied and sometimes opposite functions simultaneously. In this review, we summarize and detail clinical and experimental evidence for, and underlying mechanisms of, the dual impact of neutrophils' functions, both supporting and inhibiting cancer development. We first discuss the effects of various basic functions of neutrophils, namely direct cytotoxicity, secretion of reactive oxygen species (ROS), nitric oxide (NO) and proteases, NETosis, autophagy and modulation of other immune cells, on tumor growth and metastatic progression. We then describe the clinical evidence for pro- vs anti-tumor functions of neutrophils in human cancer. We believe and show that the "net" impact of neutrophils in cancer is the sum of a complex balance between contradicting effects which occur simultaneously.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Metastasis; Myeloid-derived suppressor cells; Neutrophils; Phenotypic modulation; Tumor microenvironment

Mesh:

Substances:

Year:  2021        PMID: 34974960     DOI: 10.1016/j.smim.2021.101582

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  6 in total

1.  Clinical assessment and molecular mechanism of the upregulation of Toll-like receptor 2 (TLR2) in myocardial infarction.

Authors:  Ming-Jie Li; Shi-Bai Yan; Hao Dong; Zhi-Guang Huang; Dong-Ming Li; Yu-Lu Tang; Yan-Fang Pan; Zhen Yang; Hong-Bo Pan; Gang Chen
Journal:  BMC Cardiovasc Disord       Date:  2022-07-15       Impact factor: 2.174

Review 2.  Perspectives for 3D-Bioprinting in Modeling of Tumor Immune Evasion.

Authors:  Rafał Staros; Agata Michalak; Kinga Rusinek; Krzysztof Mucha; Zygmunt Pojda; Radosław Zagożdżon
Journal:  Cancers (Basel)       Date:  2022-06-26       Impact factor: 6.575

Review 3.  Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils.

Authors:  Leonie M Behrens; Timo K van den Berg; Marjolein van Egmond
Journal:  Cancers (Basel)       Date:  2022-07-11       Impact factor: 6.575

4.  Phosphoserine phosphatase as an indicator for survival through potentially influencing the infiltration levels of immune cells in neuroblastoma.

Authors:  Liang Zeng; Xiao-Yun Liu; Kai Chen; Liang-Jun Qin; Feng-Hua Wang; Lei Miao; Le Li; Hai-Yun Wang
Journal:  Front Cell Dev Biol       Date:  2022-08-26

Review 5.  Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors.

Authors:  Stephen John Ralph; Maxwell J Reynolds
Journal:  Cancer Immunol Immunother       Date:  2022-08-17       Impact factor: 6.630

Review 6.  Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance.

Authors:  Xiaoting Zhou; Yanghong Ni; Xiao Liang; Yi Lin; Biao An; Xiang He; Xia Zhao
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.